Mustang Bio Announces $12.8M Grant to Fund Phase I Trial of CAR-T Therapy in Malignant Glioma
News
Related Biotechnology, Pharmaceutical and Healthcare News
The funds will be used to support two expanded arms of the
Phase I trial.
Original Article: Mustang Bio Announces $12.8M Grant to Fund Phase I Trial of CAR-T Therapy in Malignant Glioma
NEXT ARTICLE
More From BioPortfolio on "Mustang Bio Announces $12.8M Grant to Fund Phase I Trial of CAR-T Therapy in Malignant Glioma"